Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CRL: Charles River Laboratories International, Inc. Stock Analysis | finqOS
Healthcare · Medical - Diagnostics & Research
The Story
CRL
The Story
CRL
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Revenue growth
-1.9% / yr
Operating margin
11.8%
ROIC
7.1%
Financially safe
Strong
Debt / equity
1.04×
Interest coverage
4.5×
Current ratio
1.36×
Charles River Laboratories International, Inc.
CRL
New York Stock Exchange
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Charles River Laboratories International, Inc.
CRL
New York Stock Exchange
·
USD
·
Closed
$232.51
−0.90%
$232.51
−$2.11 (0.90%)
52W Range
90th
pctl
Volume
0.42×
avg
Mkt Cap
11.20B
USD
P/E
-62.0
TTM
Div Yield
–
ann
52W Range
90th
pctl
Volume
0.42×
avg
Market Cap
11.20B
USD
P/E Ratio
-62.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings